These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11910738)

  • 1. [Advances in the development of new antimycobacterial agents. The alkylsulfanyl group--a pharmacophore for antimycobacterial activity].
    Klimesová V; Kocí J; Zahajská L
    Ceska Slov Farm; 2002 Jan; 51(1):26-36. PubMed ID: 11910738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the development of new antitubercular agents from a group of 5-membered heterocyclic compounds containing various heteroatoms].
    Waisser K; Drhová L
    Ceska Slov Farm; 1999 Sep; 48(5):195-203. PubMed ID: 10566239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the development of new antitubercular agents from a group of 5-membered heterocyclic compounds containing one type of heteroatom].
    Waisser K; Drhová L
    Ceska Slov Farm; 1999 Jul; 48(4):147-55. PubMed ID: 10566236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in the development of antitubercular agents containing no heterocyclic compounds in the pharmacophore. Part 2. Other derivatives except carboxylic acids].
    Waisser K; Drazková K
    Ceska Slov Farm; 2004 May; 53(3):124-30. PubMed ID: 15218733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in the development of new antitubercular agents from a group of monocyclic 6-membered heterocyclic compounds with a greater number of nitrogen atoms].
    Waisser K; Holý P; Bures O
    Ceska Slov Farm; 2000 Nov; 49(6):268-77. PubMed ID: 11367545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the development of antitubercular agents containing no heterocyclics in the pharmacophore. Part 1. Derivatives of carboxylic acid].
    Waisser K; Drazková K
    Ceska Slov Farm; 2003 Mar; 52(2):73-81. PubMed ID: 12754927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimycobacterial activity of fluorenizid salts].
    Zarichna OZ
    Mikrobiol Z; 2007; 69(5):65-9. PubMed ID: 18217356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the development of new antitubercular agents from a group of ortho-condensed heterocyclic compounds. Part 1. Compounds containing one heteroatom per six-membered ring].
    Waisser K; Bures O; Holý P
    Ceska Slov Farm; 2001 Jul; 50(4):159-65. PubMed ID: 11475887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
    Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
    Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in the development of new antitubercular agents from orthocondensed heterocyclic compounds. Part 3. Substances containing several types of heteroatoms in the six-membered ring].
    Waisser K; Bures O; Holý P
    Ceska Slov Farm; 2001 Nov; 50(6):267-73. PubMed ID: 11797194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenyl salicylates - a new group of potential antituberculotics.
    Waisser K; Novotná E; Kuneš J; Solaříková J
    Ceska Slov Farm; 2012 Dec; 61(6):282-4. PubMed ID: 23387858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids].
    Waisser K; Cizmárik J; Drazková K; Kaustová J
    Ceska Slov Farm; 2002 May; 51(3):140-4. PubMed ID: 12058355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing an antituberculosis compounds database and data mining in the search of a motif responsible for the activity of a diverse class of antituberculosis agents.
    Prakash O; Ghosh I
    J Chem Inf Model; 2006; 46(1):17-23. PubMed ID: 16426035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the development of new antitubercular agents from pyridine derivatives].
    Waisser K; Holý P; Bures O
    Ceska Slov Farm; 2000 Sep; 49(5):211-20. PubMed ID: 11077726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oriented development of antituberculotics: salicylanilides.
    Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
    Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the development of new antitubercular agents from a group of orthocondensed heterocyclic compounds. Part 2. Substances containing more nitrogen atoms in the 6-membered ring].
    Waisser K; Bures O; Holý P
    Ceska Slov Farm; 2001 Sep; 50(5):211-8. PubMed ID: 11579686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds.
    Nefzi A; Appel J; Arutyunyan S; Houghten RA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5169-75. PubMed ID: 19632841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.